| JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases A Kumar, UK Singh, SG Kini, V Garg, S Agrawal, PK Tomar, P Pathak, ... Future medicinal chemistry 7 (15), 2065-2086, 2015 | 198 | 2015 |
| Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective A Kumar, AK Singh, H Singh, V Vijayan, D Kumar, J Naik, S Thareja, ... Pharmaceuticals 16 (2), 299, 2023 | 54 | 2023 |
| Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids S Ankit Kumar, K Adarsh, S Harshwardhan, S Pankaj, P Harshali, ... Pharmaceuticals 15 (9), 1071, 2022 | 52* | 2022 |
| Evaluation of Polyherbal Ayurvedic Formulation ‘Peedantak Vati’ for Antiinflammatory and Analgesic Properties VRA Acharya Balkrishna, Ravikant Ranjan, Sachin S Sakat, Vinay K. Sharma ... Journal of Ethnopharmacology 235, 361-374, 2019 | 31 | 2019 |
| 1, 2, 4-Triazole Scafolds: Recent Advances and Pharmacological Applications APP Anjali Thakur, Puspraj S. Gupta, Parjanya kumar shukla Int. J. Curr. Res. Aca. Rev 4 (2), 277-296, 2016 | 27 | 2016 |
| Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking J Novak, H Rimac, S Kandagalla, P Pathak, V Naumovich, M Grishina, ... Journal of Biomolecular Structure and Dynamics 40 (19), 9347-9360, 2022 | 22 | 2022 |
| Quinazoline clubbed 1, 3, 5-triazine derivatives as VEGFR2 kinase inhibitors: Design, synthesis, docking, in vitro cytotoxicity and in ovo antiangiogenic activity P Pathak, PK Shukla, V Kumar, A Kumar, A Verma Inflammopharmacology 26, 1441-1453, 2018 | 21 | 2018 |
| Quinazoline based 1, 3, 5‐triazine derivatives as cancer inhibitors by impeding the phosphorylated RET tyrosine kinase pathway: Design, synthesis, docking, and QSAR study P Pathak, V Naumovich, M Grishina, PK Shukla, A Verma, V Potemkin Archiv der Pharmazie 352 (9), 1900053, 2019 | 18 | 2019 |
| Molecular dynamics analysis of phytochemicals from Ageratina adenophora against COVID-19 main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE2) NP Neupane, AK Karn, IH Mukeri, P Pathak, P Kumar, S Singh, IA Qureshi, ... Biocatalysis and Agricultural Biotechnology 32, 101924, 2021 | 17 | 2021 |
| Metal Complexes in cancer treatment: Journey so far A Kumar Singh, A Kumar, H Singh, P Sonawane, P Pathak, M Grishina, ... Chemistry & Biodiversity 20 (4), e202300061, 2023 | 16 | 2023 |
| Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine–sulfonamide hybrids as selective BRAF V600E inhibitors AK Singh, J Novak, A Kumar, H Singh, S Thareja, P Pathak, M Grishina, ... RSC advances 12 (46), 30181-30200, 2022 | 16 | 2022 |
| 1, 2, 4‐Triazole‐conjugated 1, 3, 4‐thiadiazole hybrid scaffolds: A potent ameliorant of carrageenan‐induced inflammation by lessening proinflammatory mediators P Pathak, PK Shukla, V Naumovich, M Grishina, A Verma, V Potemkin Archiv der Pharmazie 353 (1), 1900233, 2020 | 15 | 2020 |
| Green synthesis of silver nanoformulation of Scindapsus officinalis as potent anticancer and predicted anticovid alternative: Exploration via experimental and computation methods AV Manish Pathak, PrateekPathak, Habibullah Khalilullah, MariaGrishina ... Biocatalysis and Agricultural Biotechnology 35 (10), 102072, 2021 | 14 | 2021 |
| Silica catalyzed one pot synthesis of hybrid thiazolidin-4-one derivatives as anti-tubercular and anti-inflammatory agent by attenuating COX-2 pathway P Pathak, PK Shukla, V Naumovich, M Grishina, V Potemkin, A Verma Synthetic Communications 49 (20), 2725-2759, 2019 | 13 | 2019 |
| Hybrid 4‐Aminoquinoline‐1, 3, 5‐triazine derivatives: Design, synthesis, characterization, and antibacterial evaluation P Pathak, A Thakur, HR Bhat, UP Singh Journal of Heterocyclic Chemistry 52 (4), 1108-1113, 2015 | 13 | 2015 |
| Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin–1, 2, 4‐triazole scaffolds P Pathak, J Novak, PK Shukla, M Grishina, V Potemkin, A Verma Archiv der Pharmazie 354 (6), 2000473, 2021 | 12 | 2021 |
| Hybrid Quinazoline 1, 3, 5‐Triazines as Epidermal Growth Factor Receptor (EGFR) Inhibitors with Anticancer Activity: Design, Synthesis, and Computational Study P Pathak, H Rimac, M Grishina, A Verma, V Potemkin ChemMedChem 16 (5), 822-838, 2021 | 12 | 2021 |
| Attenuation of hepatic and breast cancer cells by Polygonatum verticillatum embedded silver nanoparticles AV Manish Pathak, Prateek Pathak, Hrvoje Rimac, Maria Grishina, Uday Bagale ... Biocatalysis and Agricultural Biotechnology 30 (101863), 2020 | 11 | 2020 |
| A triterpene glochidon from Phyllanthus debilis: Isolation, computational studies, and antidiabetic activity evaluation A Verma, P Pathak, H Rimac, H Khalilullah, V Kumar, M Grishina, ... Biocatalysis and Agricultural Biotechnology 36, 102138, 2021 | 10 | 2021 |
| Polyphenolic rich extract of Oroxylum indicum alleviate β-glucuronidase activity via down-regulate oxidative stress: Experimental and computational studies P Pathak, J Novak, V Naumovich, M Grishina, A Balkrishna, N Sharma, ... Biocatalysis and Agricultural Biotechnology 29, 101804, 2020 | 10 | 2020 |
Amita VermaSam Higginbottom University of Agriculture, Technology and Sciences, AllahabadVerified email at shiats.edu.in
